Evaxion Biotech Concludes Large Non-rodent Animal Infection Studies, Testing Antigens From Evaxion's Preclinical EVX-b1 Vaccine Candidate Against Staphylococcus Aureus, Studies Showed EVX-b1 Antigens Significantly Reduced Disease Burden
Evaxion Biotech完成了大型非啮齿动物感染研究,测试了Evaxion针对金黄色葡萄球菌的临床前eVx-B1候选疫苗的抗原,研究表明 eVx-B1 抗原显著减轻了疾病负担